Keywords: strong, vivo, data, ablynx, antiviral, nanobody, belgian

Strong in vivo data on Ablynx' antiviral Nanobody

Article | 19 January 2009

Print This

Belgian drug discovery firm Ablynx says it has completed studies showing that antiviral antibodies derived from its Nanobodies platform give ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in